Afuco™ Anti-ERBB2 ADCC Therapeutic Antibody (Margetuximab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant chimeric (mouse/human) antibody expressed in CHO binding to human ERBB2. Margetuximab is a monoclonal antibody designed for the treatment of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-761 |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | ERBB2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IF, IP, Neut, FuncS, ELISA, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |